Phase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical ...
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
The MarketWatch News Department was not involved in the creation of this content. -- Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous ...
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2. The ...
These findings represent a crucial advancement in wound care, paving the way for more effective treatment options and improved patient outcomes. To address this, researchers conducted a study using ...
A new study from Karolinska Institutet maps the cellular and molecular dynamics of human wound healing in exceptional detail. The study was published in Cell Stem Cell. Self-healing of wounds is vital ...
When you’ve had a wound that required stitches, the recovery period can feel frustratingly slow. Whether from surgery, an accident, or another injury, properly cared for stitches not only heal faster ...
CAMBRIDGE, England--(BUSINESS WIRE)--SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and ...
SolasCure Completes Phase II Clinical Trial, Demonstrating Accelerated Healing With Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data confirms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results